Omnicell Inc
(FRA:OC9)
€
45
0.6 (1.35%)
Market Cap: 2.07 Bil
Enterprise Value: 2.10 Bil
PE Ratio: 0
PB Ratio: 1.77
GF Score: 71/100 Omnicell Inc at Bank of America Global Healthcare Conference Transcript
May 11, 2023 / 03:00PM GMT
Release Date Price:
€61.5
(+1.65%)
Allen Charles Lutz
BofA Securities, Research Division - Associate
Kathleen, I think you had some statements to make?
Kathleen Nemeth
Omnicell, Inc. - SVP of IR
Yes, I did. Good morning, everyone. Welcome to the Omnicell presentation. We'd like to welcome those of you also joining us on the webcast today.
Questions & Answers
Allen Charles Lutz
BofA Securities, Research Division - Associate
Maybe walk through the opportunity that you've seen within Advanced Services.
Randall A. Lipps
Omnicell, Inc. - Founder, Executive Chairman, President & CEO
Yes, we're transforming the pharmacy care delivery model. And our primary strategy to do that is with these Advanced Services. Every single advanced service comes with an ROI. That is the first premise of putting forth a new service. And that ROI-driven model is -- gets a lot of attraction from customers because they have problems they have not been able to solve without partnerships.
It's not just a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot